Bybit don start spot trading for UK again under framework wey align with FCA
Bybit don resume spot trading for UK users after dem pause for months, bring back about 100 spot pairs and P2P services while dem still keep derivatives and some products restricted. The relaunch follow continued talk with the UK Financial Conduct Authority (FCA) and dem dey use FCA-aligned arrangement — with authorised firm Archax wey approve Bybit’s financial promotions for UK — to meet local financial promotion standards. Bybit talk say dem don strengthen KYC, AML and transaction monitoring and dem go roll out extra UK-tailored products slowly. The move show say crypto dey grow for UK and regulators still dey work (new rules targeted by 2027). For traders: access again to Bybit’s spot liquidity for UK fit change local order flow, fit make spreads tight or wide depending on flows, and fit affect short-term price moves for big tokens. Compliance-focused marketing through an FCA-authorised approver reduce legal risk for outreach to UK retail, but the changing regulatory regime fit change product availability and compliance costs over time.
Neutral
Di reintroducing Bybit spot trading for UK na neutral go small-positive ting for spot market liquidity but e no clear say e go boost prices. Short-term impact: when liquidity return to one big offshore venue, e fit tighten spreads and increase order book depth for listed tokens, fit reduce short-term volatility for some pairs while e fit cause temporary price moves as flows dem reallocate. Derivatives still dey restricted, so leverage-driven directional pressure wey dey often amplify bullish or bearish moves no go strong. Medium-to-long term: compliance wey align with FCA-authorised approver reduce regulatory tail risk for UK retail access, wey fit grow local order flow sustainably; but pending UK rule changes (target 2027) and possible future restrictions fit increase compliance costs or product limitations, wey fit cap clear bullish case. Overall, net effect na increased market access and liquidity but price-direction implications mixed because product limits remain and regulatory uncertainty dey.